help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Deuxchaisnes, C. N.
Right arrow Articles by Chayen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Deuxchaisnes, C. N.
Right arrow Articles by Chayen, J.

Journal of Clinical Endocrinology & Metabolism, Vol 53, 1105-1109, Copyright © 1981 by Endocrine Society

ARTICLES

Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type I

CN de Deuxchaisnes, JA Fischer, MA Dambacher, JP Devogelaer, CE Arber, JM Zanelli, JA Parsons, N Loveridge, L Bitensky and J Chayen

Circulating levels of parathyroid hormone (PTH) in six patients with pseudohypoparathyroidism type I (PSPI) have been measured by two immunoassays and by cytochemical bioassay and compared with measurements in normal subjects and patients with clinically defined hyper- and hypoparathyroidism. In all PSPI patients, the levels of immunoreactive PTH were in the hyperparathyroid range, whereas the bioactive levels were either in the normal or close to the normal range. In one patient from whom the dihydrotachysterol therapy was withdrawn, both immunoreactive and bioactive PTH concentrations increased. The finding that the PTH measured by RIA in these PSPI patients may have reduced biological activity may explain some of the clinical findings of hypoparathyroidism in this syndrome.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
S. M. Jan de Beur, C.-L. Ding, M. C. LaBuda, T. B. Usdin, and M. A. Levine
Pseudohypoparathyroidism 1b: Exclusion of Parathyroid Hormone and Its Receptors as Candidate Disease Genes
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2239 - 2246.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. A. Fischer, F. Egert, E. Werder, and W. Born
An Inherited Mutation Associated with Functional Deficiency of the {alpha}-Subunit of the Guanine Nucleotide-Binding Protein Gs in Pseudo- and Pseudopseudohypoparathyroidism
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 935 - 938.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society